CVS Health (CVS)
(Delayed Data from NYSE)
$55.15 USD
-1.16 (-2.06%)
Updated May 2, 2024 04:00 PM ET
After-Market: $55.19 +0.04 (0.07%) 7:58 PM ET
4-Sell of 5 4
A Value F Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CVS 55.15 -1.16(-2.06%)
Will CVS be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CVS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CVS
Company News for May 2, 2024
CVS Health's (CVS) Q1 Earnings Miss Estimates, Margins Up
CVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
CVS Health (CVS) Reports Q1 Earnings: What Key Metrics Have to Say
CVS Health (CVS) Misses Q1 Earnings and Revenue Estimates
CVS Health (CVS) Stock Drops Despite Market Gains: Important Facts to Note
Other News for CVS
10 Health Care Stocks Whale Activity In Today's Session
CVS Health Stock: Free-Falling After Major Earnings Miss, Blame Game Begins
Carvana upgraded, Block downgraded: Wall Street's top analyst calls
CVS Health price target lowered by $24 at Truist, here's why
Analysts Offer Insights on Healthcare Companies: CVS Health (CVS) and SurModics (SRDX)